Literature DB >> 759576

Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid.

L J Major, D L Murphy, S Lipper, E Gordon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 759576     DOI： 10.1111/j.1471-4159.1979.tb04533.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN： 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  12 in total

1.  Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.

Authors:  R Heintz; D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.

Authors:  N A Garrick; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.

Authors:  I A Paterson; B A Davis; D A Durden; A V Juorio; P H Yu; G Ivy; W Milgram; A Mendonca; P Wu; A A Boulton
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

4.  Plasma amine oxidase activities in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase.

Authors:  D L Murphy; K B Sims; F Karoum; N A Garrick; A de la Chapelle; E M Sankila; R Norio; X O Breakefield
Journal:  J Neural Transm Gen Sect       Date:  1991

5.  Role of monoamine oxidase type A and B on the dopamine metabolism in discrete regions of the primate brain.

Authors:  M K Lakshmana; B S Rao; N K Dhingra; R Ravikumar; S Sudha; B L Meti; T R Raju
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

6.  Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.

Authors:  S H Kennedy; B A Davis; G M Brown; C G Ford; J d'Souza
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

7.  Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction.

Authors:  D Pickar; R M Cohen; D C Jimerson; C R Lake; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Norrie disease gene is distinct from the monoamine oxidase genes.

Authors:  K B Sims; L Ozelius; T Corey; W B Rinehart; R Liberfarb; J Haines; W J Chen; R Norio; E Sankila; A de la Chapelle
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

9.  Localization of monoamine oxidase A and B and semicarbazide-sensitive amine oxidase in human peripheral tissues.

Authors:  D Ramonet; M Rodríguez; J Saura; J M Lizcano; M Romera; M Unzeta; C Finch; E Billett; N Mahy
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

10.  Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.

Authors:  T Sunderland; P N Tariot; R M Cohen; P A Newhouse; A M Mellow; E A Mueller; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.